Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank97
5Y CAGR+85.6%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+85.6%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
22x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 258.71% |
| Q2 2025 | -1072.61% |
| Q1 2025 | -29.03% |
| Q4 2024 | -33.20% |
| Q3 2024 | -12.54% |
| Q2 2024 | -34.91% |
| Q1 2024 | -22.87% |
| Q4 2023 | -21.24% |
| Q3 2023 | -17.67% |
| Q2 2023 | -12.08% |
| Q1 2023 | -15.30% |
| Q4 2022 | -10.80% |
| Q3 2022 | -9.34% |
| Q2 2022 | -8.84% |
| Q1 2022 | -53.98% |
| Q4 2021 | -3.65% |
| Q3 2021 | 253.32% |
| Q2 2021 | 1779.69% |
| Q1 2021 | -249.04% |
| Q4 2020 | -101.31% |
| Q3 2020 | 11.74% |
| Q2 2020 | -84.59% |
| Q1 2020 | -24.44% |
| Q4 2019 | -38.40% |
| Q3 2019 | -50.51% |
| Q2 2019 | -20.49% |
| Q1 2019 | -17.69% |
| Q4 2018 | -18.07% |
| Q3 2018 | -13.37% |
| Q2 2018 | 21.32% |
| Q1 2018 | -17.02% |
| Q4 2017 | -37.23% |
| Q3 2017 | 128.66% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2015 | -29.36% |
| Q3 2015 | 169.62% |
| Q2 2015 | 0.00% |
| Q1 2015 | 0.00% |